MiMedx Group (MDXG)
(Delayed Data from NSDQ)
$5.93 USD
-0.20 (-3.26%)
Updated Sep 24, 2024 04:00 PM ET
After-Market: $5.93 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
C Value A Growth C Momentum A VGM
Cash flow Statements
Fiscal Year End for MiMedx Group, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 67.44 | -30.20 | -10.29 | -49.28 | -25.58 |
Depreciation/Amortization & Depletion | 3.93 | 4.51 | 6.24 | 9.13 | 9.02 |
Net Change from Assets/Liabilities | -18.42 | -9.03 | -14.08 | -15.69 | -20.05 |
Net Cash from Discontinued Operations | -8.16 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | -18.02 | 16.82 | 16.14 | 25.58 | -2.79 |
Net Cash From Operating Activities | 26.78 | -17.89 | -1.98 | -30.26 | -39.41 |
Property & Equipment | -1.99 | -1.49 | -3.22 | -4.23 | -1.75 |
Acquisition/ Disposition of Subsidiaries | 0.00 | -1.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | -0.17 | -0.17 | -0.18 | -0.33 | 2.26 |
Net Cash from Investing Activities | -2.16 | -2.66 | -3.40 | -4.56 | 0.50 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -8.52 | -0.54 | -3.31 | 98.08 | -1.37 |
Issuance (Repayment) of Debt | -0.05 | -0.04 | -0.04 | -24.37 | 70.88 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | -12.14 | -6.65 |
Net Cash from Financing Activities | -8.57 | -0.58 | -3.35 | 61.56 | 62.86 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 16.05 | -21.13 | -8.73 | 26.74 | 23.95 |
Cash at Beginning of Period | 65.95 | 87.08 | 95.81 | 69.07 | 45.12 |
Cash at End of Period | 82.00 | 65.95 | 87.08 | 95.81 | 69.07 |
Diluted Net EPS | 0.37 | -0.33 | -0.15 | -0.77 | -0.24 |
Fiscal Year End for MiMedx Group, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 26.68 | 9.06 | 67.44 | 4.75 | -3.78 |
Depreciation/Amortization & Depletion | 1.90 | 0.82 | 3.93 | 3.53 | 2.56 |
Net Change from Assets/Liabilities | -9.29 | -11.59 | -18.42 | -8.30 | -6.58 |
Net Cash from Discontinued Operations | -0.93 | -0.81 | -8.16 | 0.00 | 0.00 |
Other Operating Activities | 9.44 | 8.50 | -18.02 | 16.53 | 11.53 |
Net Cash From Operating Activities | 27.79 | 5.98 | 26.78 | 16.52 | 3.73 |
Property & Equipment | -1.25 | -1.14 | -1.99 | -1.56 | -0.93 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | -5.68 | -4.88 | -0.17 | -0.11 | -0.09 |
Net Cash from Investing Activities | -6.93 | -6.02 | -2.16 | -1.67 | -1.03 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | -1.49 | -1.39 | -8.52 | 0.41 | 0.02 |
Issuance (Repayment) of Debt | 19.27 | -30.47 | -0.05 | -0.04 | -0.02 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -51.60 | -1.61 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | -33.83 | -33.47 | -8.57 | 0.37 | 0.00 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -12.96 | -33.51 | 16.05 | 15.21 | 2.70 |
Cash at Beginning of Period | 82.00 | 82.00 | 65.95 | 65.95 | 65.95 |
Cash at End of Period | 69.04 | 48.49 | 82.00 | 81.16 | 68.65 |
Diluted Net EPS | 0.12 | 0.06 | 0.37 | 0.06 | 0.00 |